Title | Nontraditional markers of glycemia: associations with microvascular conditions. |
Publication Type | Journal Article |
Year of Publication | 2011 |
Authors | Selvin E, Francis LMA, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL, Steffes MW |
Journal | Diabetes Care |
Volume | 34 |
Issue | 4 |
Pagination | 960-7 |
Date Published | 2011 Apr |
ISSN | 1935-5548 |
Keywords | Aged, Aged, 80 and over, Blood Glucose, Cross-Sectional Studies, Diabetes Mellitus, Female, Fructosamine, Glycated Hemoglobin A, Glycation End Products, Advanced, Humans, Male, Middle Aged, Odds Ratio, Serum Albumin |
Abstract | OBJECTIVE: To compare the associations of nontraditional (fructosamine, glycated albumin, 1,5-anhydroglucitol [1,5-AG]) and standard (fasting glucose, HbA(1c)) glycemic markers with common microvascular conditions associated with diabetes mellitus. RESEARCH DESIGN AND METHODS: We conducted a cross-sectional study of 1,600 participants (227 with a history of diabetes and 1,323 without) from the Atherosclerosis Risk in Communities (ARIC) Study, a community-based population. We conducted logistic regression analyses of the associations of diabetes-specific tertiles of fructosamine, glycated albumin, 1/(1,5-AG), fasting glucose, and HbA(1c) with prevalence of chronic kidney disease, albuminuria, and retinopathy after adjustment for demographic, clinical, and lifestyle variables. RESULTS: We observed significant positive trends in the associations of each marker with albuminuria and retinopathy, even after accounting for demographic, clinical, and lifestyle factors (all P trends CONCLUSIONS: In cross-sectional analyses, two serum markers of glycemia-glycated albumin and fructosamine-are as, or more strongly, associated with microvascular conditions as HbA(1c). These markers may be useful in settings where whole blood is not available. Whether they might complement or outperform HbA(1c) in terms of long-term predictive value requires further investigation. |
DOI | 10.2337/dc10-1945 |
Alternate Journal | Diabetes Care |
PubMed ID | 21335368 |
PubMed Central ID | PMC3064058 |
Grant List | N01HC55020 / HL / NHLBI NIH HHS / United States K01-DK-076595 / DK / NIDDK NIH HHS / United States N01HC55018 / HL / NHLBI NIH HHS / United States N01-HC-55016 / HC / NHLBI NIH HHS / United States K01 DK076595 / DK / NIDDK NIH HHS / United States N01-HC-55019 / HC / NHLBI NIH HHS / United States N01-HC-55015 / HC / NHLBI NIH HHS / United States P60 DK079637 / DK / NIDDK NIH HHS / United States N01HC55019 / HL / NHLBI NIH HHS / United States R21 DK080294 / DK / NIDDK NIH HHS / United States K24 DK062222 / DK / NIDDK NIH HHS / United States N01-HC-55022 / HC / NHLBI NIH HHS / United States P60-DK-079637 / DK / NIDDK NIH HHS / United States R01 DK089174 / DK / NIDDK NIH HHS / United States N01HC55022 / HL / NHLBI NIH HHS / United States N01-HC-55021 / HC / NHLBI NIH HHS / United States N01HC55015 / HL / NHLBI NIH HHS / United States R21-DK-080294 / DK / NIDDK NIH HHS / United States N01-HC-55020 / HC / NHLBI NIH HHS / United States K24-DK-62222 / DK / NIDDK NIH HHS / United States N01HC55016 / HL / NHLBI NIH HHS / United States N01-HC-55018 / HC / NHLBI NIH HHS / United States N01HC55021 / HL / NHLBI NIH HHS / United States |